INTRODUCTION
Patients who have bullous lung disease in the presence of diffuse parenchymal involvement (emphysematous or non-emphysematous) should be evaluated on an individual basis and surgery should be performed for patients in whom even a small increase in pulmonary function might be of major benefit (1) . Computed tomography scan (CT-scan), bronchography and angiography can outline bullae that are not visible on a plain chest radiograph (2) . Bullae that enlarge enough to 
MATERIALS AND METHODS
The present study was conducted in the Department of Mean chest tube drainage in the 1st 24 hours post operatively was 450 ± 220 ml with a range of 250 -900 ml.
Chest tubes were removed 9 -14 days postoperatively (average day 5) excluding the 2 patients who developed empyema. Minor complications were seen distributed among 15 patients. Major complications were seen in only 5 patients in the form of air leak > 1 week in 3 and empyema in 2 patients. All three patients who expired had diffuse disease in the surrounding lung parenchyma.
Overall mortality rate at the end of study period was 5.56%. The change in ABG parameters was statistically insignificant while the improvement in PFT parameters and subjective dyspnea score was statistically significant (Table 1) had bronchiectatic changes.
The mortality rate was reported by Gunstensen et al, to be 9.5%. This rate was reported by Fitzgerald as 2.1% and by Potgeiter et al, as 9.5%. (7) Antonio Palla et al (6) reported a mortality rate of zero after 3-6 months, 7.3% after 1 year, 4.9% after 2 years with an overall mortality rate of 12.2% after 5 years (5 of 41 patients). All 5 patients had underlying diffuse emphysematous changes. The mortality rate in our study was quite comparable with that observed in the above studies and consistent with the fact that deaths occur almost exclusively in those with underlying diffuse disease in their surrounding lung parenchyma.
We draw the following conclusions from our study:
-The most common underlying lung pathology was primary bullous lung disease followed by COPD.
-The most common presenting complaint was spontaneous pneumothorax.
-The presented patients were usually tall young adults in their fourth decade of life (31 -40 years) with a history of smoking. -Improvement in mean FEV1, FVC and FEV1 / FVC was statistically significant, with FEV 1 being the most reliable indicator of postoperative progress.
-Improvement in subjective dyspnea score was statistically significant and showed an inverse correlation with FEV 1 .
-The above ABG and PFT parameters as well as the dyspnea score showed similar improvement when considered separately among those with diffuse disease and those without diffuse disease, though the former had poorer baseline values and postoperative improvement.
-Complications occurred more commonly in those with diffuse disease.
-Mortality was seen exclusively in those with diffuse disease.
We conclude that surgery for bullous lung disease is needed more frequently in our community since we have a high number of patients with primary bullous lung disease and localized disease and these patients usually have a good surgical outcome. Therefore, late diagnosis and potentially fatal complications like pneumothorax and recurrent infections would be prevented in them. Those with underlying diffuse disease and severely decreased FEV 1 (especially below 1 L) also benefit from surgery but careful patient selection is necessary.
